Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Principia Biopharma Inc (PRNB)

Principia Biopharma Inc (PRNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Principia Biopharma Inc. is a clinical stage biopharmaceutical company. It offers reversible covalent small molecule drugs for the treatment of cancers. The company's product pipeline consists of PRN1008, PRN1371 and PRN2246 which are in clinical stage. Principia Biopharma Inc. is based in San Francisco, United States.

Fiscal Year End Date: 12/31

Income Statement

(Values in U.S. Thousands) Dec, 2019 Dec, 2018 Dec, 2017 Dec, 2016 Sep, 2017
Sales 35,160 69,140 5,250 0 -25,860
Sales Growth -49.15% +1,216.95% unch +100.00% unch
Net Income -53,790 18,170 -28,700 -30,630 8,250
Net Income Growth -396.04% +163.31% +6.30% -471.27% unch

Balance Sheet

(Values in U.S. Thousands) Dec, 2019 Dec, 2018 Dec, 2017 Dec, 2016 Sep, 2017
Total Assets 382,740 195,520 43,500 7,550 1,900
Total Assets Growth +95.75% +349.47% +476.16% +297.37% unch
Total Liabilities 23,760 25,660 186,970 124,200 0
Total Liabilities Growth -7.40% -86.28% +50.54% unch unch

Cash Flow

(Values in U.S. Thousands) Dec, 2019 Dec, 2018 Dec, 2017 Dec, 2016 Sep, 2017
Operating Cash Flow -42,550 -21,170 26,850 -24,840 -6,370
Operating Cash Flow Growth -100.99% -178.85% +208.09% -289.95% unch
Net Cash Flow 4,970 -6,100 35,190 -11,420 1,900
Change in Net Cash Flow +181.48% -117.33% +408.14% -701.05% unch
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot